626 related articles for article (PubMed ID: 31811882)
21. Prevalence of hepatitis C virus in adult population in the Czech Republic - time for birth cohort screening.
Chlibek R; Smetana J; Sosovickova R; Gal P; Dite P; Stepanova V; Pliskova L; Plisek S
PLoS One; 2017; 12(4):e0175525. PubMed ID: 28406947
[TBL] [Abstract][Full Text] [Related]
22. Association between rapid utilisation of direct hepatitis C antivirals and decline in the prevalence of viremia among people who inject drugs in Australia.
Iversen J; Dore GJ; Catlett B; Cunningham P; Grebely J; Maher L
J Hepatol; 2019 Jan; 70(1):33-39. PubMed ID: 30367897
[TBL] [Abstract][Full Text] [Related]
23. Feasibility and effectiveness of HCV viraemia testing at harm reduction sites in Georgia: A prospective three-arm study.
Shilton S; Markby J; Japaridze M; Chihota V; Shadaker S; Gvinjilia L; Tsereteli M; Alkhazashvili M; Butsashvili M; Stvilia K; Ruiz RJ; Asatiani A; Adamia E; Easterbrook P; Khonelidze I; Gamkrelidze A
Liver Int; 2022 Apr; 42(4):775-786. PubMed ID: 35129278
[TBL] [Abstract][Full Text] [Related]
24. Recently acquired hepatitis C virus infection among people living with human immunodeficiency virus at a university hospital in Taiwan.
Huang MH; Sun HY; Ho SY; Chang SY; Hsieh SM; Sheng WH; Chuang YC; Huang YS; Su LH; Liu WC; Su YC; Hung CC
World J Gastroenterol; 2021 Oct; 27(37):6277-6289. PubMed ID: 34712032
[TBL] [Abstract][Full Text] [Related]
25. Microenvironment Eradication of Hepatitis C: A Novel Treatment Paradigm.
Cuadrado A; Llerena S; Cobo C; Pallás JR; Mateo M; Cabezas J; Fortea JI; Alvarez S; Pellón R; Crespo J; Echevarría S; Ayesa R; Setién E; Lopez-Hoyos M; Crespo-Facorro B; Agüero J; Chueca N; Garcia F; Calleja JL; Crespo J
Am J Gastroenterol; 2018 Nov; 113(11):1639-1648. PubMed ID: 29946175
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of alcohol use behavior among patients cured through HCV elimination program in Georgia.
Butsashvili M; Gulbiani L; Kanchelashvili G; Kamkamidze T; Kajaia M; Gudavadze S; Kamkamidze G
BMC Res Notes; 2024 Jun; 17(1):160. PubMed ID: 38858781
[TBL] [Abstract][Full Text] [Related]
27. An educate, test, and treat programme towards elimination of hepatitis C infection in Egypt: a community-based demonstration project.
Shiha G; Metwally AM; Soliman R; Elbasiony M; Mikhail NNH; Easterbrook P
Lancet Gastroenterol Hepatol; 2018 Nov; 3(11):778-789. PubMed ID: 30030068
[TBL] [Abstract][Full Text] [Related]
28. Hepatitis C Virus Screening and Care: Complexity of Implementation in Primary Care Practices Serving Disadvantaged Populations.
Turner BJ; Rochat A; Lill S; Bobadilla R; Hernandez L; Choi A; Guerrero JA
Ann Intern Med; 2019 Dec; 171(12):865-874. PubMed ID: 31791065
[TBL] [Abstract][Full Text] [Related]
29. Clinical Findings of HCV Chronic Infection in Undocumented Immigrants and Low-Income Refugees in Three Areas of Southern Italy.
Sagnelli E; Alessio L; Sagnelli C; Gualdieri L; Pisaturo M; Minichini C; Di Caprio G; Starace M; Onorato L; Scotto G; Macera M; Coppola N
Ann Hepatol; 2018; 17(1):47-53. PubMed ID: 29311411
[TBL] [Abstract][Full Text] [Related]
30. Hepatitis C virus core antigen is cost-effective in community-based screening of active hepatitis C infection in Taiwan.
Wang JH; Chen CH; Chang CM; Feng WC; Lee CY; Lu SN
J Formos Med Assoc; 2020 Jan; 119(1 Pt 3):504-508. PubMed ID: 31350109
[TBL] [Abstract][Full Text] [Related]
31. Decentralised same day test and treatment of hepatitis C levering existing peer support networks among men who inject drugs: feasibility and effectiveness.
Rajkumar N; Khumukcham LS; Thangjam D; Singh S; Khwairakpam G; Shilton S; Goel A
Harm Reduct J; 2024 May; 21(1):98. PubMed ID: 38769517
[TBL] [Abstract][Full Text] [Related]
32. Determination of serum hepatitis C virus (HCV) core protein using a novel approach for quantitative evaluation of HCV viraemia in anti-HCV-positive patients.
Komatsu F; Takasaki K
Liver; 1999 Oct; 19(5):375-80. PubMed ID: 10533794
[TBL] [Abstract][Full Text] [Related]
33. Regression of liver fibrosis over a 24-week period after completing direct-acting antiviral therapy in patients with chronic hepatitis C receiving care within the national hepatitis C elimination program in Georgia: results of hepatology clinic HEPA experience.
Dolmazashvili E; Abutidze A; Chkhartishvili N; Karchava M; Sharvadze L; Tsertsvadze T
Eur J Gastroenterol Hepatol; 2017 Nov; 29(11):1223-1230. PubMed ID: 28857900
[TBL] [Abstract][Full Text] [Related]
34. Defining the hepatitis C cure cascade in an Urban health system using the electronic health record.
Miller LS; Millman AJ; Lom J; Osinubi A; Ahmed F; Dupont S; Rein D; Vellozzi C; Harris AM
J Viral Hepat; 2020 Jan; 27(1):13-19. PubMed ID: 31505088
[TBL] [Abstract][Full Text] [Related]
35. A platform in the use of medicines to treat chronic hepatitis C (PLATINUM C): protocol for a prospective treatment registry of real-world outcomes for hepatitis C.
Ramsay J; Marsh J; Pedrana A; Andric N; Norman R; Cheng W; Webb S; Zeps N; Bellgard M; Graves T; Hellard M; Snelling T
BMC Infect Dis; 2020 Oct; 20(1):802. PubMed ID: 33121439
[TBL] [Abstract][Full Text] [Related]
36. Identification and Clinical Management of Persons with Chronic Hepatitis C Virus Infection - Cherokee Nation, 2012-2015.
Mera J; Vellozzi C; Hariri S; Carabin H; Drevets DA; Miller A; Reilley B; Essex W; Gahn D; Lyons L; Leston J; Ward JW
MMWR Morb Mortal Wkly Rep; 2016 May; 65(18):461-6. PubMed ID: 27172175
[TBL] [Abstract][Full Text] [Related]
37. High-Yield Birth-Cohort Hepatitis C Virus Screening and Linkage to Care Among Underserved African Americans, Atlanta, Georgia, 2012-2013.
Miller LS; Rollin F; Fluker SA; Lundberg KL; Park B; Quairoli K; Niyibizi NK; Spaulding AC
Public Health Rep; 2016; 131 Suppl 2(Suppl 2):84-90. PubMed ID: 27168666
[TBL] [Abstract][Full Text] [Related]
38. Performance of Hepatitis C Virus (HCV) Core Antigen Assay in the Diagnosis of Recently Acquired HCV Infection among High-Risk Populations.
Sun HY; Liu WD; Wang CW; Wei YJ; Lin KY; Huang YS; Su LH; Chen YT; Liu WC; Su YC; Chen YW; Chuang YC; Lu PL; Hung CC; Yu ML
Microbiol Spectr; 2022 Jun; 10(3):e0034522. PubMed ID: 35579445
[TBL] [Abstract][Full Text] [Related]
39. ELIMINATE: a PCR record-based macroelimination project for systematic recall of HCV-RNA-positive persons in Austria.
Schwarz C; Bauer D; Dorn L; Jachs M; Hartl L; Chromy D; Weseslindtner L; Pfisterer N; Hennlich B; Stückler A; Strassl R; Voill-Glaninger A; Hübl W; Willheim M; Köhrer K; Jansen-Skoupy S; Tomez S; Krugluger W; Madl C; Schwarz M; Balcar L; Semmler G; Brinkmann L; Burghart L; Antonitsch L; Weidinger G; Riedl F; Laferl H; Kurteva V; Traugott M; Hind J; Wenisch C; Aburaia A; Sebesta C; Schmid D; Rothweiler S; Remetic J; Gschwantler M; Maieron A; Reiberger T
Wien Klin Wochenschr; 2024 May; 136(9-10):278-288. PubMed ID: 37773541
[TBL] [Abstract][Full Text] [Related]
40. Detection of antibody to hepatitis C virus E2 recombinant antigen among samples indeterminate for anti-HCV after wide serological testing and correlation with viremia. The Spanish Study Group for Blood Donors at Risk of Transmission of HCV.
León P; López JA; Elola C; Domingo CJ; Echevarria JM
Vox Sang; 1996; 70(4):213-6. PubMed ID: 9123926
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
